METCURE THERAPEUTICS
MetCure Therapeutics is a biotechnology company that develops new drugs to treat metastatic cancer. It has developed a prostate cancer cell line that exhibits the characteristics of malignant, chemo-resistant human cancer cells. Using its proprietary high-throughput screening platform, MetCure is testing and identifying compounds that serve as effective drugs against these lethal cells. MetCure has identified LG1980 as one lead compound and outlined the mechanism LG1980 uses to attack prostate cancer cells. Other cancer stem cell inhibitors are also being explored.
METCURE THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science Medical
Founded:
2013-01-01
Address:
Augusta, Georgia, United States
Country:
United States
Website Url:
http://www.metcuredotcom.wordpress.com
Status:
Active
Total Funding:
0
Similar Organizations
Innovative BioTherapies
Innovative BioTherapies is a biotechnology company that develops medical devices to solve unmet medical needs.
Trishula Therapeutics
Trishula Therapeutics is a biotechnology company that focus on developing cancer medicines.
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - MetCure Therapeutics
Official Site Inspections
http://www.metcuredotcom.wordpress.com
- Host name: 192.0.78.12
- IP address: 192.0.78.12
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110